Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

43,499 stories, page 565 of 725

Advanced search

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT07243925: Effect of Family Participation-Based Intervention Before Coronary Artery Bypass Grafting (CABG) on Patients' Anxiety, Independence, and Psychological Resilience: A Randomized Controlled Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT07161414: A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT06917209: Evaluation of the Efficacy of Dissociation-Focused Cognitive Behavior Therapy

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT06483139: Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT06149481: Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT05412212: Brief Educational Video for Patients Prescribed LTBI Treatment

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT05335876: Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT05258071: A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT05143957: A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT04439201: Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT03834493: Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT03192267: Early Rheumatoid Arthritis Lung Disease Study

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT03000244: Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT02977299: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source

🇺🇸Jul 9Researchclinicaltrials.govTier 1 · Trial registry

NCT01883505: A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease Patients

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

FDA plans rules to rein in drug ads, enable proactive release of CRLs, and more

RAPSOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026?

The Motley FoolOriginal source

🇺🇰Jul 9Regulatorygov.ukTier 1 · Regulatory source

Life Sciences Sector Plan: One Year On

Progress report on delivering the Life Sciences Sector Plan.

UK Department of Health and Social CareOriginal source

🇺🇰Jul 9Regulatorygov.ukTier 1 · Regulatory source

Life Sciences Sector Plan

The Life Sciences Sector Plan sets out a vision and an action plan to drive growth, innovation, and...

UK Department of Health and Social CareOriginal source

🇺🇰Jul 9Regulatorygov.ukTier 1 · Regulatory source

UK life sciences attracts £3bn investment, creating jobs and faster patient treatments

Life Sciences sector attracts over £3 billion in new public-private investment in 12 months, reflect...

UK Department of Health and Social CareOriginal source

🌍Jul 9discoverynews.google.comTier 2 · Trade media

Organ-on-a-chip, Organoids, but Drug Testing on Whole Organs? This Startup is Betting On It

MedCity NewsOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Local biotech companies may get option to report finances twice a year

KALWOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Rhythm Pharmaceuticals Announces NEJM Publication of Phase 3 TRANSCEND Trial Results for Setmelanotide in Acquired Hypothalamic Obesity

Quiver QuantitativeOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Rhythm’s obesity drug data lands in NEJM after 52-week Phase 3 trial

Stock TitanOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Alpha-1 Antitrypsin Deficiency Drug Enters Ph3 Trial

respiratory-therapy.comOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

FDA unveils 3-year blueprint to expand drug development for minor uses and minor species

DVM360Original source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

New York pushes to become major US biotech hub

BioProcess InternationalOriginal source

🇺🇸Jul 9Industryinvestors.amneal.comTier 1 · Company source

Amneal and Adalvo Announce FDA Acceptance for Review of Two U.S. ANDAs for Generic Tirzepatide Autoinjector

Amneal Pharmaceuticals RSSOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

$180M financing supports head-to-head Phase 3 IPF drug trial

Pulmonary Fibrosis NewsOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Alector (ALEC) sees GSK end antibody collaboration while repaying $10.4M loan

Stock TitanOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Tarsus pays $75M for eye drug candidate with Phase 3 ahead

Stock TitanOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

AI as Reinvention | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

RSV Antiviral Zelicapavir Enters Late-stage Clinical Trials

respiratory-therapy.comOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Biotech Merger Tests AI Patient Stratification Against RA’s 70% Treatment Gap

Tech TimesOriginal source

🇮🇹Jul 9Industryrecordati.comTier 1 · Company source

On behalf of Respighi BidCo S.p.A – CONSOB approved the Offer Document

RecordatiOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Global clinical trial launches to test self-given, long-acting gMG drug

Myasthenia Gravis NewsOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Ai-Generated Drug Rentosertib Trialed for Idiopathic Pulmonary Fibrosis

respiratory-therapy.comOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Major biotech company laying off 103 more employees in fifth round of cuts since mid-2025

MassLiveOriginal source

🇫🇷Jul 9Industrypierre-fabre.comTier 1 · Company source

Les Laboratoires Pierre Fabre augmentent leur participation au capital de MiYé pour accélérer son développement en pharmacies

Pierre FabreOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

FDA collects ghee, honey samples during inspection

Pioneer EdgeOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Scoop to soup: FDA freezes licence of Mumbai's iconic ice cream outlet after rats found on premises

The Economic TimesOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

DEA Proposes Schedule I Ban for the First “Gas Station Drug," Tianeptine

FilterOriginal source

🌍Jul 9discoverynews.google.comTier 2 · Trade media

FDA halts release of new drug rejection letters while working to formalize policy

Fierce BiotechOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Errant FDA Policy and Dramatic Rise of Device and Drug Recalls : News Article

Independent InstituteOriginal source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Powering scientific discovery: BYOKG and GraphRAG for intelligent pharmaceutical research

Amazon Web Services (AWS)Original source

🌍Jul 9discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical company to build rare manufacturing facility in Sugar Land

KHOUOriginal source

🇺🇰Jul 9Regulatorygov.ukTier 1 · Regulatory source

Campylobacter infection: annual data

Annual data of reported Campylobacter infections in England since 2006.

UK Health Security AgencyOriginal source

🌍Jul 9discoverynews.google.comTier 2 · Trade media

AstraZeneca, GSK intensify China ties with Sino Biopharm deals

BioPharma DiveOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

FDA suspends licence of iconic Mumbai ice cream outlet K Rustom over food safety violations

The Indian ExpressOriginal source

🇺🇸Jul 8Devicesbtig.comTier 1 · Company source

BTIG Expands Energy and Infrastructure Investment Banking Coverage with the Addition of Michael Bodino and Chris Gibson

BTIGOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Keenova Therapeutics Reports Positive Phase 3 XIAFLEX Data

grafa.comOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Regulatory update on the 2026 Drugs to Watch

ClarivateOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Sana Biotech heads to EASD with diabetes cell therapy update

Longevity.TechnologyOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut?

Insider MonkeyOriginal source

🌍Jul 8discoverynews.google.comTier 3 · Aggregated media

Community pharmacy could help ease £2.7bn delayed discharge bill

The Pharmaceutical JournalOriginal source

🌍Jul 8discoverynews.google.comTier 2 · Trade media

Europe will accelerate its review of RevMed’s drug

STATOriginal source

🌍Jul 8discoverynews.google.comTier 2 · Trade media

Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant

Pharmaceutical TechnologyOriginal source

🌍Jul 8discoverynews.google.comTier 2 · Trade media

FDA cracks down on illegal ketamine sellers amid nearing ‘psychedelic revolution’

Pharmaceutical TechnologyOriginal source

🇺🇰Jul 8Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance report, week 51 report: data to week 50 (data up to 13 December 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

UK Health Security AgencyOriginal source

🇺🇰Jul 8Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance report, week 50 report: data to week 49 (data up to 6 December 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

UK Health Security AgencyOriginal source